IMMU-16. IDENTIFICATION OF TUMOR REJECTION ANTIGENS FOR PRECISION ADOPTIVE CELLULAR THERAPY FOR PEDIATRIC GLIOMAS

BACKGROUND: Identifying tumor rejection antigens remains a major barrier to developing effective antigen-directed immunotherapeutics and their application to pediatric brain tumors. Recent progress in the field of cancer immunogenomics has facilitated the search for tumor-specific antigens by applyi...

Descripción completa

Detalles Bibliográficos
Autores principales: Trivedi, Vrunda, Yang, Changlin, Ogando-Rivas, Elizabeth, Dyson, Kyle, Mitchell, Duane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Immunology/Immunotherapy - IMMU
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260164/
http://dx.doi.org/10.1093/neuonc/noad073.203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260164/
http://dx.doi.org/10.1093/neuonc/noad073.203

Ejemplares similares